Sunshine Biopharma, Inc. announced a private placement for the gross proceeds of $5,000,000 on March 28, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3908 USD | +28.89% |
|
+18.42% | -98.56% |
May. 21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
May. 20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.56% | 6.06M | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- SBFM Stock
- News Sunshine Biopharma, Inc.
- Sunshine Biopharma, Inc. announced that it has received $5 million in funding